Drug Profile
Research programme: dual RON/c-Met inhibitors - Amgen
Alternative Names: Compound ILatest Information Update: 16 Mar 2010
Price :
$50
*
At a glance
- Originator Amgen
- Class Small molecules
- Mechanism of Action Proto-oncogene protein c-met inhibitors; RON protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Nov 2007 Preclinical trials in Cancer in USA (unspecified route)